Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.

导出 LinkOut

翻译打印收藏纠错

第一作者： Christianne,Groeneveldt

第一单位： Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands.

作者： Christianne,Groeneveldt ^[1] ; Priscilla,Kinderman ^[2] ; Lisa,Griffioen ^[1] ; Olivia,Rensing ^[2] ; Camilla,Labrie ^[1] ; Diana J M,van den Wollenberg ^[3] ; Rob C,Hoeben ^[3] ; Matt,Coffey ^[4] ; Houra,Loghmani ^[4] ; Els M E,Verdegaal ^[1] ; Marij J P,Welters ^[1] ; Sjoerd H,van der Burg ^[1] ; Thorbald,van Hall ^[1] ; Nadine,van Montfoort ^[2]

作者单位： Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands. ^[1] Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands. ^[2] Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands. ^[3] Oncolytics Biotech Incorporated, Calgary, Canada. ^[4]

主题词人类(Humans);动物(Animals);小鼠(Mice);抗体, 中和(Antibodies, Neutralizing);溶瘤病毒疗法(Oncolytic Virotherapy);溶瘤病毒(Oncolytic Viruses);呼肠病毒科(Reoviridae);抗体, 病毒(Antibodies, Viral);肿瘤(Neoplasms);T淋巴细胞(T-Lymphocytes);免疫疗法(Immunotherapy)

DOI 10.1158/2326-6066.CIR-23-0480

PMID 38194598

发布时间 2024-03-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer immunology research

2024年12卷3期

334-349页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.

Cancer immunology research

相似文献

Cancer immunology research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.

Cancer immunology research

相似文献

Cancer immunology research

相关期刊

检索历史清除